Characterizing the Toxicity and Dose-Effect Profile of Tramadol Ingestions in Children

Pediatric Emergency Care

Volumn 35, Issue 2, 2019, Pages 117-120

  Stassinos, Gina L ^a   Gonzales, Lawrence ^a   Klein Schwartz, Wendy ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

overdose; toxicity; tramadol

Indexed keywords

ACTIVATED CARBON; BENZODIAZEPINE DERIVATIVE; INFUSION FLUID; NALOXONE; PARACETAMOL PLUS TRAMADOL; TRAMADOL; NARCOTIC ANALGESIC AGENT;

AGITATION; ARTICLE; ARTIFICIAL VENTILATION; ATAXIA; BRADYCARDIA; CHILD; COMA; CONFUSION; CYANOSIS; DELUSION; DIZZINESS; DROWSINESS; DRUG EXPOSURE; DYSTONIA; EPILEPTIC STATE; FEMALE; HALLUCINATION; HUMAN; HYPERTENSION; HYPOTENSION; INTUBATION; LETHARGY; MALE; MIOSIS; MYDRIASIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRURITUS; RESPIRATION DEPRESSION; RESPIRATORY ARREST; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; TACHYCARDIA; TREMOR; VOMITING; DRUG OVERDOSE; INFANT; POISON CENTER;

ANALGESICS, OPIOID; CHILD, PRESCHOOL; DRUG OVERDOSE; FEMALE; HUMANS; INFANT; MALE; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES; TRAMADOL;

EID: 85013436476     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0000000000001084     Document Type: Article

References (16)

1. Spiller HA Gorman SE Villalobos D. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997; 35: 361-364.
2. Talaie H Panahandeh R Fayaznouri M. Dose-independent occurrence of seizure with tramadol. J Med Toxicol. 2009; 5: 63-67.
3. Finkel JC Rose JB Schmitz ML. An evaluation of the efficacy and tolerability of oral tramadol hydrochloride tablets for the treatment of postsurgical pain in children. Anesth Analg. 2002; 94: 1469-1473.
4. Payne KA Roelofse JA Shipton EA. Pharmacokinetics of oral tramadol drops for postoperative pain relief in children aged 4 to 7 years-a pilot study. Anesth Prog. 2002; 49: 109-112.
5. Rose JB Finkel JC Arquedas-Mohs A. Oral tramadol for the treatment of pain of 7-30 days' duration in children. Anesth Analg. 2003; 96: 78-81.
6. Marquardt KA Alsop JA Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 2005; 39: 1039-1044.
7. Farajidana H Hassanian-Moghaddam H Zamani N. Tramadol-induced seizures and trauma. Eur Rev Med Pharmacol Sci. 2012; 16 (supp. 1): 34-37.
8. Lintz W Barth H Osterloh G. Bioavailability of enteral tramadol formulations. 1st communication: capsules. Arzneimittelforschung. 1986; 36: 1278-1283.
9. Grond S Meuser T Uragg H. Serum concentrations of tramadol enantiomers during patient-controlled analgesia. Br J Clin Pharmacol. 1999; 48: 254-257.
10. Viitanen H Annila P. Analgesic efficacy of tramadol 2 mg kg(-1) for paediatric day-case adenoidectomy. Br J Anaesth. 2001; 86: 572-575.
11. Subrahmanyam V Renwick AB Walters DG. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab Dispos. 2001; 29: 1146-1155.
12. Poon CY Lee CKK. Pediatric pharmacy practice. In: Allen LV Jr Adejare A Desselle SP, eds. Remington: The Science and Practice of Pharmacy. 22nd ed. Philadelphia, PA: Pharmaceutical Press; 2012: chap 112.
13. Murthy BV Pandya KS Booker PD. Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration. Br J Anaesth. 2000; 84: 346-349.
14. Wagner J Abdel-Rahman SM. Pediatric pharmacokinetics. Pediatr Rev. 2013; 34: 258-269.
15. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005; 5: 6-13.
16. Jaramillo JE Marchbanks B Willis B. Evaluation of completeness of selected poison control center data fields. J Med Syst. 2010; 34: 499-507.